Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Reduced Caloric Intake Semaglutide suppresses appetite, which leads to a significant reduction in the number of calories you consume
The standard 16-week escalation path looks like this: weeks 1-4 at 0.25 mg, weeks 5-8 at 0.5 mg, weeks 9-12 at 1.0 mg, weeks 13-16 at 1.5 mg, and then continuation at higher doses if tolerated
Technical Information Compound Name: Retatrutide Peptide Classification: Triple Hormone Receptor Agonist (GLP-1 / GIP / Glucagon Receptor Agonist) Molecular Formula: CHNO Appearance: White to off-white lyophilized powder Solubility: Typically soluble in bacteriostatic water or suitable research-grade diluents Research Category: Metabolic and multi-receptor pathway research peptide Common Research Areas GLP-1, GIP, and glucagon receptor signaling Glucose-homeostasis investigations Appetite and satiety-related research Adipose and energy-balance studies Metabolic and obesity-related investigations Cardiometabolic and endocrine-signaling pathways For Laboratory and Research Use Only Not for human consumption or therapeutic use
However, this advantage diminishes with combination therapy
US$ 29.96
US$ 27.51
US$ 21.91
